Mesenchymal stem cells (MSCs) are known to be capable of suppressing immune responses and offer therapeutic potential for achieving transplantation tolerance. This review will discuss the impacts of MSCs on transplant immunity and focus on the potential role of MSCs in protecting islet grafts from both rejection and autoimmune attack
Mesenchymal stem cells (MSCs) can be derived from adult bone marrow, fat and several foetal tissues....
Clinical islet transplantation is a -cell replacement strategy that represents a possible definitive...
Insulin injection is currently the main therapy for type 1 diabetes (T1D) or late stage of severe ty...
Mesenchymal stem cells (MSCs) therapy has brought a great enthusiasm to the treatment of various imm...
Islet cell transplantation has therapeutic potential to treat type 1 diabetes, which is characterize...
Pancreatic islet transplantation is a promising cell-based therapy for type 1 diabetes (insulin-depe...
BACKGROUND: Pancreatic islet transplantation is a promising cell-based therapy for type 1 diabetes (...
Aims: Mesenchymal stem cells (MSCs) are multipotent cells with immunomodulatory properties. We teste...
OBJECTIVE Mesenchymal stem cells (MSCs) are known to be capable of suppressing immune responses, but...
Islet transplantation is used therapeutically in a minority of patients with type 1 diabetes. Succes...
Transplantation of human islets is an attractive alternative to daily insulin injections for patient...
OBJECTIVE—Mesenchymal stem cells (MSCs) are known to be capable of suppressing immune responses, but...
Transplantation of human islets is an attractive alternative to daily insulin injections for patient...
Purpose To evaluate the efficacy of human bone marrow-derived mesenchymal stem cells (hBMSCs) as gen...
Although the muscle is one of the preferable transplant sites in islet transplantation, its transpla...
Mesenchymal stem cells (MSCs) can be derived from adult bone marrow, fat and several foetal tissues....
Clinical islet transplantation is a -cell replacement strategy that represents a possible definitive...
Insulin injection is currently the main therapy for type 1 diabetes (T1D) or late stage of severe ty...
Mesenchymal stem cells (MSCs) therapy has brought a great enthusiasm to the treatment of various imm...
Islet cell transplantation has therapeutic potential to treat type 1 diabetes, which is characterize...
Pancreatic islet transplantation is a promising cell-based therapy for type 1 diabetes (insulin-depe...
BACKGROUND: Pancreatic islet transplantation is a promising cell-based therapy for type 1 diabetes (...
Aims: Mesenchymal stem cells (MSCs) are multipotent cells with immunomodulatory properties. We teste...
OBJECTIVE Mesenchymal stem cells (MSCs) are known to be capable of suppressing immune responses, but...
Islet transplantation is used therapeutically in a minority of patients with type 1 diabetes. Succes...
Transplantation of human islets is an attractive alternative to daily insulin injections for patient...
OBJECTIVE—Mesenchymal stem cells (MSCs) are known to be capable of suppressing immune responses, but...
Transplantation of human islets is an attractive alternative to daily insulin injections for patient...
Purpose To evaluate the efficacy of human bone marrow-derived mesenchymal stem cells (hBMSCs) as gen...
Although the muscle is one of the preferable transplant sites in islet transplantation, its transpla...
Mesenchymal stem cells (MSCs) can be derived from adult bone marrow, fat and several foetal tissues....
Clinical islet transplantation is a -cell replacement strategy that represents a possible definitive...
Insulin injection is currently the main therapy for type 1 diabetes (T1D) or late stage of severe ty...
DOI
Add to ORKG